<DOC>
	<DOCNO>NCT00094341</DOCNO>
	<brief_summary>The purpose study determine preference RA patient new Enbrel速 ( etanercept ) pre-filled syringe patient already take Enbrel速 .</brief_summary>
	<brief_title>Preference Rheumatoid Arthritis ( RA ) Patients Enbrel速 ( Etanercept ) Auto-Injector Versus Enbrel速 Pre-Filled Syringes</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Have establish RA diagnosis determine ACR criterion Be current user etanerceptlyophilized preparation least 4 consecutive week etanercept dose either weekly twice weekly regimen Subject must able self inject Give write informed consent Subject currently enrol yet complete least 30 day since end investigational device drug trial ( ) , subject receive investigational agent ( ) Subject childbearing potential pregnant ( e.g. , positive HCG test ) breastfeed Elective surgery plan study period Subjects allergic latex</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Arthritis</keyword>
	<keyword>Rheumatology</keyword>
</DOC>